The rise of Sildenafil initially sparked a surge for the drug industry, however recent shifts present a murky scenario for shareholders. Lower-cost competitors are eroding profits, and ongoing patent challenges add https://stevekvei005475.digiblogbox.com/65572330/sildenafil-and-big-pharma-a-volatile-play